MetaModix
PrivateLast Round
VC Round
Jan 26, 2023
Total Funding Raised
$5.24M
Company Overview
MetaModix is a biotechnology company that develops nonsurgical, drug-free device therapies for the treatment of metabolic diseases including Type 2 Diabetes, obesity, and NASH.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MetaModix Comparables
Compare MetaModix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Keyron Medical Technology | 91% | |
| Morphic Medical | 88% | |
| GI Windows Surgical | 83% | |
MetaModix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 26, 2023 | ||||
| Series A | Mar 28, 2017 | ||||
| Series A | Jun 24, 2015 | ||||
| VC Round | Apr 7, 2014 | ||||
| VC Round | Mar 28, 2013 | ||||
Seed | Feb 15, 2012 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 28, 2017
$1.2M round raised
- Jun 24, 2015
Raised $1.75M in Series A funding.
MetaModix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MetaModix's valuation, stock price, and market status.